Trials / Terminated
TerminatedNCT00760461
Domperidone in Refractory Gastroparesis
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to prescribe oral domperidone for patients with gastroparesis who have failed or suffered adverse effects from standard medical therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Domperidone | 10 mg 4 times daily 20 mg 4 times daily 30 mg 4 times daily |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2008-09-26
- Last updated
- 2017-08-18
- Results posted
- 2017-08-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00760461. Inclusion in this directory is not an endorsement.